Company / Depreciation & Amortization
Lipocine Inc. Depreciation & Amortization History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$41.1K
FY2025
5-year range
$380 / $41.1K
FY2021-FY2025
Trend
+43.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 3 consecutive years, from $380 in FY2022 to $41,106 in FY2025.
Based on SEC 10-K filings.
$41,106 in FY2025 with a 5-year CAGR of +21.6%.
Increased from $9,453 to $41,106 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +376.5%
- 5-Year CAGR
- +21.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Lipocine Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 5-year CAGR of +21.6%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 43.4% year-over-year.
- Peak depreciation & amortization was recorded in FY2013.
Company context
Key Data Points
- Altman Z-Score -1.16 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $41.1K | +43.4% |
| FY2024 | $28.7K | +203.2% |
| FY2023 | $9.5K | +2387.6% |
| FY2022 | $380 | -89.3% |
| FY2021 | $3.6K | -77.0% |
| FY2020 | $15.4K | -17.0% |
| FY2019 | $18.6K | -41.8% |
| FY2018 | $32.0K | -24.9% |
| FY2013 | $42.6K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026